GoBears: They are searching for that additional penny or half penny to add more but they know it is going up. Kind of counterintuitive as new investors hear about AMBS they would visit this board and leave with mixed sentiment to say the least. CRAO ODD should be on deck. BIO gives AMBS a real good venue for 1:1's with medium to big Pharma to showcase their growing portfolio. Small revenue deals for Lympro will bolster any offer for Dx Division. Any deal with money immediately increases the value for any offer for any aspect of the company that is on the table.